PCACTIT Stock Latest News
Private CompaniesActithera Highlights Progress Toward Clinical Radioligand Development1w agoACTIT
Private CompaniesActithera Strengthens Clinical Operations Leadership for Radioligand Therapy Pipeline3w agoACTIT
Private CompaniesActithera Highlights Oncology Focus Ahead of ESMO 2026 Participation3w agoACTIT
Private CompaniesActithera Strengthens Clinical Leadership With New Global Head of Clinical Affairs1M agoACTIT
Private CompaniesActithera Leadership Emphasizes Innovation Amid Competitive Biopharma Landscape1M agoACTIT
Private CompaniesActithera Showcases Radioligand Therapy Expertise at Discovery on Target Conference1M agoACTITPrivate CompaniesActithera Strengthens Clinical Drug Supply Leadership to Support Growing Pipeline1M agoACTIT
Private CompaniesActithera Highlights Growth Trajectory and Leadership Shift in Nordic Biotech Ecosystem1M agoACTIT
Private CompaniesActithera Bolsters Leadership as It Sharpens Focus on Next-Generation Oncology2M agoACTIT
Private CompaniesActithera Highlights Strategic Focus on Next-Generation Oncology Modalities2M agoACTIT
Private CompaniesActithera Strengthens Leadership Team Ahead of Clinical Advancement2M agoACTIT- Private CompaniesActithera Strengthens Radiopharmaceutical Leadership With Key Imaging Hire2M agoACTIT
Private CompaniesActithera Strengthens Clinical Leadership With Veteran Radiopharmaceutical Executive2M agoACTIT- Private CompaniesActithera Highlights Focus on AI-Enabled Drug Discovery and Radioligand Therapies4M agoACTIT
- Private CompaniesActithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Symposium5M agoACTIT
Private CompaniesActithera Highlights Role in Oslo Radiopharmaceutical Ecosystem Event5M agoACTIT
Private CompaniesActithera – Weekly Recap5M agoACTITPrivate CompaniesActithera Steps Up FAP Theranostic Focus and Strategic Outreach Ahead of SNMMI 20265M agoACTIT
Private CompaniesActithera CMO to Join Expert Panel on FAP-Targeted Theranostics at SNMMI 20265M agoACTIT